Mutual of America Capital Management’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-27,211
| Closed | -$785K | – | 1442 |
|
|
2024
Q3 | $785K | Sell |
27,211
-255
| -0.9% | -$7.35K | 0.01% | 1062 |
|
|
2024
Q2 | $1.05M | Sell |
27,466
-1,188
| -4% | -$45.6K | 0.01% | 1018 |
|
|
2024
Q1 | $1.68M | Sell |
28,654
-2,328
| -8% | -$137K | 0.02% | 957 |
|
|
2023
Q4 | $1.85M | Sell |
30,982
-10,532
| -25% | -$630K | 0.02% | 926 |
|
|
2023
Q3 | $1.58M | Sell |
41,514
-2,470
| -6% | -$94K | 0.02% | 953 |
|
|
2023
Q2 | $4.01M | Buy |
43,984
+17,132
| +64% | +$1.56M | 0.05% | 589 |
|
|
2023
Q1 | $1.77M | Sell |
26,852
-1,237
| -4% | -$81.6K | 0.02% | 940 |
|
|
2022
Q4 | $1.45M | Buy |
28,089
+378
| +1% | +$19.5K | 0.02% | 977 |
|
|
2022
Q3 | $1.89M | Buy |
+27,711
| New | +$1.89M | 0.03% | 870 |
|